Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Buisseret L, Loirat D, Aftimos P, Maurer C, Punie K, Debien V, Kristanto P, Eiger D, Goncalves A, Ghiringhelli F, Taylor D, Clatot F, Van den Mooter T, Ferrero JM, Bonnefoi H, Canon JL, Duhoux FP, Mansi L, Poncin R, Barthélémy P, Isambert N, Denis Z, Catteau X, Salgado R, Agostinetto E, de Azambuja E, Rothé F, Craciun L, Venet D, Romano E, Stagg J, Paesmans M, Larsimont D, Sotiriou C, Ignatiadis M, Piccart-Gebhart M. Buisseret L, et al. Among authors: van den mooter t. Nat Commun. 2023 Nov 2;14(1):7018. doi: 10.1038/s41467-023-42744-y. Nat Commun. 2023. PMID: 37919269 Free PMC article. Clinical Trial.
Subcutaneous trastuzumab (Herceptin) versus intravenous trastuzumab for the treatment of patients with HER2-positive breast cancer: A time, motion and cost assessment study in a lean operating day care oncology unit.
Tjalma WAA, Van den Mooter T, Mertens T, Bastiaens V, Huizing MT, Papadimitriou K. Tjalma WAA, et al. Among authors: van den mooter t. Eur J Obstet Gynecol Reprod Biol. 2018 Feb;221:46-51. doi: 10.1016/j.ejogrb.2017.12.006. Epub 2017 Dec 7. Eur J Obstet Gynecol Reprod Biol. 2018. PMID: 29245056
New targets, new hopes.
Strijbos M, Van den Mooter T, Ost P. Strijbos M, et al. Among authors: van den mooter t. ESMO Open. 2022 Apr;7(2):100420. doi: 10.1016/j.esmoop.2022.100420. Epub 2022 Mar 3. ESMO Open. 2022. PMID: 35248825 Free PMC article. No abstract available.
Beta-HCG Secretion by a Pulmonary Choriocarcinoma in a Male Patient.
Devos B, Willemse C, Sterckx M, Debruyne J, Stappaerts I, Van den Mooter T, Hertoghs M, Abrams P. Devos B, et al. Among authors: van den mooter t. Case Rep Oncol Med. 2024 Jan 27;2024:8731806. doi: 10.1155/2024/8731806. eCollection 2024. Case Rep Oncol Med. 2024. PMID: 38314227 Free PMC article.
Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial.
Buisseret L, Loirat D, Aftimos P, Maurer C, Punie K, Debien V, Kristanto P, Eiger D, Goncalves A, Ghiringhelli F, Taylor D, Clatot F, Van den Mooter T, Ferrero JM, Bonnefoi H, Canon JL, Duhoux FP, Mansi L, Poncin R, Barthélémy P, Isambert N, Denis Z, Catteau X, Salgado R, Agostinetto E, de Azambuja E, Rothé F, Craciun L, Venet D, Romano E, Stagg J, Paesmans M, Larsimont D, Sotiriou C, Ignatiadis M, Piccart-Gebhart M. Buisseret L, et al. Among authors: van den mooter t. Nat Commun. 2023 Dec 12;14(1):8223. doi: 10.1038/s41467-023-44071-8. Nat Commun. 2023. PMID: 38086864 Free PMC article. No abstract available.
Palliative bladder radiotherapy: caveats in a changing landscape.
Dirix P, Strijbos M, Van den Mooter T, Vandeursen H. Dirix P, et al. Among authors: van den mooter t. Ann Palliat Med. 2020 May;9(3):1269-1271. doi: 10.21037/apm.2020.03.03. Epub 2020 Mar 24. Ann Palliat Med. 2020. PMID: 32279511 Free article. No abstract available.